Getting Here | Contact Us | A to Z of Services                          

                                            




You are here  : Home Control of Infection Control of Infection Screening Policy for MRSA
Screening Policy for MRSA
Written by Linda Fairhead   

The transmission of MRSA and the risk of MRSA infection (including MRSA bacteraemia) can only be addressed effectively if measures are taken to identify MRSA carriers as potential sources and if they are treated to reduce the risk of transmission. This requires screening of patient populations for MRSA carriage either before or on admission to identify carriers and implement a decolonisation regimen.

The normal habitat of Staphylococcus aureus, including MRSA, is human skin, particularly in the:
  • Anterior nares (nose)
  • Groin

Clinical infection with MRSA (including MRSA bacteraemia) occurs either from the patient's own resident MRSA (if he or she is an asymptomatic carrier) or by cross infection from another person who also can be an asymptomatic carrier or have a clinical infection.

Attachments:
FileFile size
Download this file (Screening Policy for MRSA.pdf)Screening Policy for MRSA.pdf54 Kb
Last Updated ( Wednesday, 17 November 2010 13:03 )